01
Cash & equivalents increased 207.9%
Cash & equivalents changed +207.9% from the comparable as-filed period.
$11.0M→$34.0MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCellectar Biosciences, Inc.'s latest supported as-filed period reports interest income of $133,359. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +207.9% from the comparable as-filed period.
Net income changed -27.2% from the comparable as-filed period.
Operating income changed -19.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CLRB · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-095460SEC ↗10-QAug 13, 2026Period Jun 30, 20260001104659-26-095426SEC ↗4/AJul 10, 2026Period Jul 8, 20260001104659-26-082761SEC ↗8-KJul 10, 2026Period Jul 7, 20260001104659-26-082719SEC ↗4Jul 8, 2026Period Jul 7, 20260001104659-26-082018SEC ↗4Jul 8, 2026Period Jul 7, 20260001104659-26-082016SEC ↗4Jul 8, 2026Period Jul 7, 20260001104659-26-082015SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 8, 2026Filed Jul 10, 2026 | Loren StefanReporting owner | Grant Or AwardDirect · amended | 15,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +90.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-082014